相关实验视频

Updated: Jun 30, 2025

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis

Published on: April 12, 2024

在女性生殖系统恶性瘤中CD276表达的临床病理特征和预后价值:元分析

Hang Su¹, Juan-Juan Hao², Yan-Bo Xu¹

¹Department of Thyroid and Breast Surgery, Hebei General Hospital, Shijiazhuang, China; Graduate School, North China University of Science and Technology, Tangshan, China.

Taiwanese journal of obstetrics & gynecology

|March 14, 2024

概括

CD276表达与女性生殖系统癌症的较差结果有关. 这种蛋白质可以作为预测不良预后的生物标志物,并在这些恶性瘤中作为免疫治疗的标.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
生物标志物生物标志物

背景情况:

CD276在女性生殖系统恶性瘤中的作用仍然存在争议.
这项研究旨在澄清CD276表达与临床病理特征以及这些癌症的预后之间的关联.

结论:

CD276可以作为一个有价值的生物标志物,用于预测女性生殖系统恶性瘤的不良预后.
CD276为这些癌症的治疗提供了免疫治疗的潜在新标.

关键词:

CD276 CD276 CD276 CD276 CD276 CD276 CD276 CD276 CD276 CD276 CD276 CD276 CD276 CD276 CD276 CD276 CD276 CD276 CD276 CD276 CD276 CD276 CD276 CD276 CD276 生殖系统的恶性瘤生殖系统的恶性瘤进行元分析分析.预测预后预测预测

更多相关视频

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Published on: August 1, 2018

相关概念视频

Disorders of the Female Reproductive System

Disorders of the Female Reproductive System

The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...